HYPR Stock Price, Hyperfine, Inc. Quote, Chart

Market Summary

0.89+0.05

Market Closed

5.95%

HYPR Stock Price

View Fullscreen

HYPR RSI Chart

HYPR Valuation

Market Cap

64.0M

Price/Earnings (Trailing)

-1.53

Price/Sales (Trailing)

5.48

EV/EBITDA

-0.02

Price/Free Cashflow

-1.53

HYPR Price/Sales (Trailing)

HYPR Profitability

EBT Margin

-358.59%

Return on Equity

-55.43%

Return on Assets

-49.07%

Free Cashflow Yield

-65.16%

HYPR Fundamentals

HYPR Revenue

Revenue (TTM)

11.7M

Rev. Growth (Yr)

25.05%

Rev. Growth (Qtr)

22.67%

HYPR Earnings

Earnings (TTM)

-41.9M

Earnings Growth (Yr)

19.01%

Earnings Growth (Qtr)

7.82%

Breaking Down HYPR Revenue

Last 7 days

12.7%

Last 30 days

-2.2%

Last 90 days

-19.8%

Trailing 12 Months

-31.5%

How does HYPR drawdown profile look like?

HYPR Financial Health

Current Ratio

9.09

HYPR Investor Care

Shares Dilution (1Y)

1.51%

Diluted EPS (TTM)

-0.59

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	11.7M	0	0	0
2023	7.9M	9.8M	9.8M	11.0M
2022	2.7M	3.8M	5.8M	6.8M
2021	594.5K	895.0K	1.2M	1.5M
2020	0	0	0	294.0K

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Hyperfine, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Feb 16, 2024	teisseyre thomas	sold	-3,585	1.11	-3,230	chief operating officer
Nov 16, 2023	teisseyre thomas	sold	-3,345	1.26	-2,655	chief operating officer
Aug 16, 2023	teisseyre thomas	sold	-6,294	2.26	-2,785	chief operating officer
Aug 16, 2023	siddiqui khan	sold	-3,907	2.26	-1,729	cmo and chief strategy officer
May 16, 2023	siddiqui khan	sold	-2,168	1.25	-1,735	cmo and chief strategy officer
Feb 16, 2023	siddiqui khan	sold	-6,442	1.39	-4,635	cmo and chief strategy officer
Feb 16, 2023	gupta alok	sold	-7,802	1.39	-5,613	chief financial officer
Dec 16, 2022	hc sponsor llc	sold	-	-	-5,534,000	-
Dec 14, 2022	sainz maria	bought	4,750	0.95	5,000	president and ceo
Dec 09, 2022	sainz maria	bought	10,561	0.85	12,425	president and ceo

Which funds bought or sold HYPR recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	JANE STREET GROUP, LLC	reduced	-31.15	-9,198	14,677	-%
May 15, 2024	Squarepoint Ops LLC	reduced	-16.34	-9,705	28,648	-%
May 15, 2024	Cresset Asset Management, LLC	unchanged	-	-1,380	11,500	-%
May 15, 2024	Avidity Partners Management LP	unchanged	-	-142,581	1,188,180	0.04%
May 15, 2024	BARCLAYS PLC	new	-	45,000	45,000	-%
May 15, 2024	BANK OF AMERICA CORP /DE/	sold off	-100	-37.00	-	-%
May 15, 2024	MERCER GLOBAL ADVISORS INC /ADV	unchanged	-	-3,000	19,000	-%
May 15, 2024	MORGAN STANLEY	reduced	-6.43	-685	3,476	-%
May 15, 2024	STATE STREET CORP	unchanged	-	-21,071	175,595	-%
May 15, 2024	CITADEL ADVISORS LLC	reduced	-62.13	-107,907	55,128	-%

Are Funds Buying or Selling HYPR?

Are funds buying HYPR calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own HYPR

No. of Funds

Unveiling Hyperfine, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	5.62%	3,175,728	SC 13G
Feb 14, 2023	hc sponsor llc	0.0%	0	SC 13G/A
Dec 20, 2022	hc sponsor llc	12.0%	6,634,000	SC 13G/A
Dec 07, 2022	rothberg jonathan m	5.3%	2,976,688	SC 13D/A

Recent SEC filings of Hyperfine, Inc.

View All Filings

Date Filed	Form Type	Document
May 16, 2024	4	Insider Trading
May 14, 2024	10-Q	Quarterly Report
May 13, 2024	8-K	Current Report
Apr 26, 2024	DEFA14A	DEFA14A
Apr 26, 2024	DEF 14A	DEF 14A
Apr 26, 2024	ARS	ARS
Apr 16, 2024	PRE 14A	PRE 14A
Mar 28, 2024	4	Insider Trading
Mar 28, 2024	4	Insider Trading
Mar 28, 2024	4	Insider Trading

Peers (Alternatives to Hyperfine, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	181.0B	40.3B	-1.75%	-4.07%	32.18	4.49	-2.84%	-3.08%
BDX	68.3B	19.7B	1.78%	-6.05%	51.24	3.46	4.82%	-17.56%
ALGN	20.4B	3.9B	-9.57%	-7.50%	44.2	5.22	5.72%	46.72%
BAX	18.0B	14.9B	-10.73%	-18.01%	6.79	1.21	2.98%	207.68%
MID-CAP
ATR	9.8B	3.5B	6.68%	24.08%	31.27	2.76	6.16%	35.06%
HSIC	9.6B	12.5B	6.31%	-2.51%	24.63	0.77	-0.61%	-18.83%
BIO	8.4B	2.6B	1.13%	-22.65%	-26.02	3.22	-6.25%	-68.62%
XRAY	5.9B	3.9B	-6.79%	-30.12%	-62.84	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	0.52%	31.17%	-216.3	8.9	30.82%	65.57%
PDCO	2.3B	6.6B	0.19%	-5.50%	11.93	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	5.94%	-10.00%	-1.91	0.41	7.94%	-1661.78%
ANIK	376.6M	169.3M	-1.13%	-2.23%	-4.9	2.23	7.49%	-244.90%
ANGO	241.9M	324.0M	-4.58%	-37.15%	-1.26	0.75	-3.19%	-337.41%
APYX	56.1M	50.5M	22.73%	-73.49%	-2.46	1.11	14.25%	-10.06%
AEMD	1.0M	3.7M	-71.83%	-87.10%	-0.09	0.28	5.77%	8.23%

Hyperfine, Inc. News

Latest updates

Hyperfine, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4
Revenue	22.7%	3,295,000	2,686,000	2,330,000	3,381,000	2,635,000	1,424,000	2,348,000	1,533,000	1,509,000	436,000	371,000	358,000	331,000	-
Gross Profit	30.9%	1,354,000	1,034,000	1,124,000	1,444,000	1,155,000	300,000	688,000	-165,000	84,000	-453,000	-338,000	-99,000	-277,000	-
Operating Expenses	-5.2%	12,004,000	12,663,000	12,883,000	13,136,000	14,190,000	13,929,000	13,970,000	23,027,000	23,855,000	25,634,000	16,052,000	14,487,000	7,528,000	-
S&GA Expenses	-20.7%	2,004,000	2,528,000	2,529,000	2,499,000	2,547,000	2,874,000	3,434,000	3,750,000	4,161,000	4,592,000	2,787,000	1,787,000	1,196,000	-
R&D Expenses	-6.6%	5,570,000	5,962,000	5,739,000	5,331,000	5,461,000	5,219,000	7,338,000	7,265,000	8,334,000	8,893,000	6,438,000	6,037,000	4,474,000	-
EBITDA Margin	10.7%	-3.50	-3.91	-4.66	-4.91	-7.62	-10.59	-14.61	-22.96	-29.90	-42.86	-19.35	-25.85	-38.92	-78.70
Income Taxes	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings Before Taxes	7.8%	-9,848,000	-10,684,000	-10,757,000	-10,637,000	-12,160,000	-13,059,000	-13,171,000	-23,159,000	-23,775,000	-26,085,000	-16,392,000	-14,580,000	-7,794,000	-
EBT Margin	10.6%	-3.59	-4.01	-4.77	-5.01	-7.75	-10.74	-14.79	-23.23	-30.23	-43.35	-19.60	-26.18	-39.41	-79.68
Net Income	7.8%	-9,848,000	-10,684,000	-10,757,000	-10,637,000	-12,160,000	-13,059,000	-13,171,000	-23,159,000	-23,775,000	-26,085,000	-16,392,000	-14,580,000	-7,794,000	-
Net Income Margin	10.6%	-3.59	-4.01	-4.77	-5.01	-7.75	-10.74	-14.79	-23.23	-30.23	-43.35	-19.60	-26.18	-39.41	-79.68
Free Cashflow	-24.1%	-12,655,000	-10,196,000	-8,984,000	-9,881,000	-13,552,000	-15,503,000	-12,967,000	-16,857,000	-27,597,000	-19,110,000	-11,004,000	-12,123,000	-7,656,000	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet															(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2019Q4
Assets	-9.3%	85.00	94.00	103	113	122	134	148	162	179	202	81.00	208	208	72.00	31.00
Current Assets	-10.4%	80.00	89.00	98.00	108	117	129	144	157	174	197	76.00	1.00	1.00	68.00	28.00
Cash Equivalents	-15.9%	63.00	75.00	85.00	94.00	104	117	132	145	162	191	65.00	77.00	86.00	64.00	26.00
Inventory	10.9%	7.00	7.00	7.00	6.00	6.00	5.00	4.00	5.00	5.00	4.00	3.00	-	-	2.00	-
Net PPE	23.6%	4.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	4.00	4.00	3.00	-	-	2.00	0.00
Liabilities	0.1%	10.00	10.00	9.00	9.00	9.00	10.00	13.00	11.00	12.00	16.00	14.00	9.00	7.00	4.00	-
Current Liabilities	0.0%	9.00	9.00	8.00	8.00	8.00	9.00	12.00	10.00	11.00	16.00	14.00	1.00	0.00	4.00	2.00
Shareholder's Equity	-10.4%	76.00	84.00	94.00	103	113	124	135	151	167	186	-	5.00	5.00	0.00	-
Retained Earnings	-3.9%	-263	-253	-243	-232	-221	-209	-196	-183	-160	-136	-110	-7.35	-5.92	-71.47	-48.04
Additional Paid-In Capital	0.3%	339	338	337	336	334	333	331	334	327	323	9.00	-	-	10.00	8.00
Shares Outstanding	0.9%	72.00	71.00	71.00	71.00	71.00	70.00	70.00	70.00	70.00	4.00	2.00	2.00	2.00	2.00	4.00
Float	-	-	-	-	116	-	-	-	121	-	-	-	204	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2019Q4
Cashflow From Operations	-25.9%	-12,510	-9,938	-8,721	-9,659	-13,491	-15,345	-12,794	-16,911	-27,289	-18,135	-9,943	-11,618	-7,486	-	-	-
Share Based Compensation	-19.9%	1,032	1,288	1,194	1,133	1,126	1,793	-2,354	7,102	4,111	3,770	1,375	1,489	267	-	-	-
Cashflow From Investing	43.8%	-145	-258	-263	-222	-61.00	-158	-173	54.00	-308	-975	-1,061	-505	-170	-	-	-
Cashflow From Financing	96.4%	55.00	28.00	39.00	58.00	49.00	5.00	-	-	-	141,328	1,264	2,965	31,210	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

HYPR Income Statement

2024-03-31

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Sales
Total sales	$ 3,295	$ 2,635
Cost of sales
Total cost of sales	1,941	1,480
Gross margin	1,354	1,155
Operating Expenses:
Research and development	5,570	5,461
General and administrative	4,430	6,182
Sales and marketing	2,004	2,547
Total operating expenses	12,004	14,190
Loss from operations	(10,650)	(13,035)
Interest income	796	869
Other income, net	6	6
Loss before provision for income taxes	(9,848)	(12,160)
Provision for income taxes	0	0
Net loss and comprehensive loss	$ (9,848)	$ (12,160)
Earnings Per Share, Basic	$ (0.14)	$ (0.17)
Earnings Per Share, Diluted	$ (0.14)	$ (0.17)
Denominator for Basic EPS - Weighted-average common stock	71,934,045	70,864,226
Denominator for Dilutive EPS - Weighted-average common stock	71,934,045	70,864,226
Device
Sales
Total sales	$ 2,704	$ 2,132
Cost of sales
Total cost of sales	1,499	1,071
Service
Sales
Total sales	591	503
Cost of sales
Total cost of sales	$ 442	$ 409

HYPR Balance Sheet

2024-03-31

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
CURRENT ASSETS:
Cash and cash equivalents	$ 63,204	$ 75,183
Restricted cash		621
Accounts receivable, less allowance of $248 and $321 as of March 31, 2024 and December 31, 2023, respectively	5,343	3,189
Unbilled receivables	895	942
Inventory	7,298	6,582
Prepaid expenses and other current assets	2,950	2,391
Total current assets	79,690	88,908
Property and equipment, net	3,706	2,999
Other long term assets	2,047	2,292
Total assets	85,443	94,199
CURRENT LIABILITIES:
Accounts payable	2,532	1,214
Deferred grant funding		621
Deferred revenue	1,527	1,453
Accrued expenses and other current liabilities	4,663	5,419
Total current liabilities	8,767	8,768
Long term deferred revenue	1,021	968
Other noncurrent liabilities	17	64
Total liabilities	9,805	9,800
COMMITMENTS AND CONTINGENCIES (NOTE 13)
STOCKHOLDERS' EQUITY:
Additional paid-in capital	339,201	338,114
Accumulated deficit	(263,570)	(253,722)
Total stockholders' equity	75,638	84,399	$ 123,722
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	85,443	94,199
Class A Common Stock
STOCKHOLDERS' EQUITY:
Common stock	5	5
Class B Common Stock
STOCKHOLDERS' EQUITY:
Common stock	2	2
Related Party
CURRENT LIABILITIES:
Due to related parties	$ 45	$ 61

About Hyperfine, Inc.

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products. Its products include Swoop Portable MR imaging system, which offers neuroimaging at the point of care. The company was incorporated in 2014 and is based in Guilford, Connecticut.

CEO	Ms. Maria Sainz
WEBSITE	https://hyperfine.io
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	136

Hyperfine, Inc. Frequently Asked Questions

What is the ticker symbol for Hyperfine, Inc.? What does HYPR stand for in stocks?

HYPR is the stock ticker symbol of Hyperfine, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Hyperfine, Inc. (HYPR)?

As of Fri May 17 2024, market cap of Hyperfine, Inc. is 64.02 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of HYPR stock?

You can check HYPR's fair value in chart for subscribers.

What is the fair value of HYPR stock?

You can check HYPR's fair value in chart for subscribers. The fair value of Hyperfine, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Hyperfine, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for HYPR so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Hyperfine, Inc. a good stock to buy?

The fair value guage provides a quick view whether HYPR is over valued or under valued. Whether Hyperfine, Inc. is cheap or expensive depends on the assumptions which impact Hyperfine, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HYPR.

What is Hyperfine, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, HYPR's PE ratio (Price to Earnings) is -1.53 and Price to Sales (PS) ratio is 5.48. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. HYPR PE ratio will change depending on the future growth rate expectations of investors.